HighVista Strategies’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25,287	Closed	-$389K	–	138
2024 Q3	$389K	Sell	25,287 -591	-2%	-$9.86K	0.13%	139
2024 Q2	$421K	Buy	+25,878	New	+$418K	0.15%	120
2023 Q4	–	Sell	-18,172	Closed	-$379K	–	127
2023 Q3	$379K	Sell	18,172 -10,619	-37%	-$288K	0.18%	126
2023 Q2	$690K	Sell	28,791 -26,783	-48%	-$595K	0.32%	92
2023 Q1	$1.05M	Sell	55,574 -1,044	-2%	-$19.9K	0.85%	35
2022 Q4	$901K	Buy	56,618 +3,300	+6%	+$51.6K	0.54%	51
2022 Q3	$872K	Buy	53,318 +13,418	+34%	+$217K	0.5%	49
2022 Q2	$562K	Buy	39,900 +5,784	+17%	+$108K	0.34%	71
2022 Q1	$826K	Buy	+34,116	New	+$826K	0.53%	55
2021 Q2	–	Sell	-16,590	Closed	-$428K	–	117
2021 Q1	$428K	Buy	16,590 +2,246	+16%	+$98.9K	0.32%	73
2020 Q4	$767K	Buy	14,344 +1,915	+15%	+$95.1K	0.49%	49
2020 Q3	$513K	Buy	12,429 +3,635	+41%	+$157K	0.37%	47
2020 Q2	$426K	Buy	+8,794	New	+$422K	0.35%	44